We are live on ! Find out more
INO icon

Inovio Pharmaceuticals
INO

94 hedge funds and large institutions have $161M invested in Inovio Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

17% more capital invested

Capital invested by funds: $137M → $161M (+$23.9M)

12% more funds holding

Funds holding: 84 → 94 (+10)

0.5% more ownership

Funds ownership: 1.93% → 2.43% (+0.5%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 28

27% less call options, than puts

Call options by funds: $2.14M | Put options by funds: $2.93M

Holders
94
Holders Change
+10
Holders Change %
+11.9%
% of All Funds
2.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
24
Reduced
28
Closed
14
Calls
$2.14M
Puts
$2.93M
Net Calls
-$787K
Net Calls Change
+$1.9M

Top Buyers

1
WA
Wasatch Advisors
Utah
+$17.9M
2
BFA
BlackRock Fund Advisors
California
+$9.65M
3
State Street
State Street
Massachusetts
+$5.75M
4
BIT
BlackRock Institutional Trust
California
+$2.67M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.93M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$2.97M
2
TA
Teachers Advisors
New York
-$2.74M
3
ARTA
A.R.T. Advisors
New York
-$1.6M
4
Goldman Sachs
Goldman Sachs
New York
-$942K
5
TCIM
TIAA CREF Investment Management
New York
-$838K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
26
BlackRock Advisors
Delaware
$936K -$65.3K -534 -6%
EA
27
Emerald Advisers
Pennsylvania
$797K -$56K -458 -6%
TA
28
Teachers Advisors
New York
$778K -$2.74M -22,438 -76%
AllianceBernstein
29
AllianceBernstein
Tennessee
$756K -$18.3K -150 -2%
KCM
30
Knoll Capital Management
Florida
$754K -$204K -1,666 -20%
SGAM
31
Smith Group Asset Management
Texas
$749K -$83.6K -684 -9%
Citigroup
32
Citigroup
New York
$691K +$114K +930 +17%
RTS
33
Round Table Services
New Jersey
$675K – – –
Swiss National Bank
34
Swiss National Bank
Switzerland
$621K +$688K +5,633 New
Ohio Public Employees Retirement System (OPERS)
35
Ohio Public Employees Retirement System (OPERS)
Ohio
$558K +$618K +5,061 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$547K – – –
AQR Capital Management
37
AQR Capital Management
Connecticut
$538K -$115K -942 -16%
Millennium Management
38
Millennium Management
New York
$502K +$557K +4,555 New
ProShare Advisors
39
ProShare Advisors
Maryland
$487K +$297K +2,429 +122%
AIG
40
American International Group
New York
$481K -$33.1K -271 -6%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$459K +$156K +1,277 +44%
Capital Fund Management (CFM)
42
Capital Fund Management (CFM)
France
$438K +$486K +3,975 New
MLICM
43
Metropolitan Life Insurance Company (MetLife)
New York
$431K +$49.4K +404 +12%
TAM
44
Tocqueville Asset Management
New York
$422K -$112K -917 -19%
NFA
45
Nationwide Fund Advisors
Ohio
$419K -$7.94K -65 -2%
Deutsche Bank
46
Deutsche Bank
Germany
$393K +$177K +1,447 +68%
Group One Trading
47
Group One Trading
Illinois
$388K -$142K -1,159 -25%
HCM
48
Highbridge Capital Management
New York
$343K -$224K -1,830 -37%
VOYA Investment Management
49
VOYA Investment Management
Georgia
$325K – – –
SCM
50
Stevens Capital Management
Pennsylvania
$317K +$352K +2,877 New
1
2
3 4 5

INO Hedge Fund Activity: Q4 2014 in Review

94 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q4 2014, worth a combined $161M — up 17% from $137M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new INO positions and 14 closed out — a net gain of 11 holders — while 24 added to existing stakes and 28 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $17.9M. The largest seller was Morgan Stanley, cutting an estimated $2.97M.

  • 94 institutional investors held Inovio Pharmaceuticals (INO) as of Q4 2014, up from 84 in Q3 2014.
  • Funds reported $161M of Inovio Pharmaceuticals stock for Q4 2014, up 17% quarter-over-quarter.
  • 25 funds opened new Inovio Pharmaceuticals positions in Q4 2014 and 14 closed out, a net change of +11 holders.
  • The largest Inovio Pharmaceuticals buyer in Q4 2014 was Wasatch Advisors, an estimated $17.9M added.
  • The largest Inovio Pharmaceuticals seller in Q4 2014 was Morgan Stanley, an estimated $2.97M sold.

Based on aggregated 13F filings for Q4 2014.